MAPK1 and breast cancer: The intratumoral expression of PEDF inhibits breast cancer cell migration and invasion by downregulating fibronectin, and, in turn, reduces the metalloproteinase-2 (MMP2)/MMP9 in the TME via p-ERK and p-AKT signaling pathways [16].